2024

Nov
13

Mpox Updates Amidst the Ongoing Global Public Health Emergency

Overview Assessment of Needs In August 2024, a new variant of mpox (clade 1b) that is behind a growing number of cases in several countries in Africa (including the Democratic Republic of Congo, Burundi, the Central African Republic, and Rwanda) led the Africa Centres for Disease Control and Prevention to declare a public (more…)

DETAIL
Nov
22

Where Are We With Hepatitis C Elimination?

Overview Assessment of Needs Combination HIV/hepatitis C virus (HCV) infection prevention, including treatment as prevention, is the global strategy for ending the HIV epidemic and achieving HCV infection elimination. This webinar will review the current state of this endeavor, including the latest prevention and treatment options. Additionally, it will discuss the barriers to (more…)

DETAIL
Dec
4

Update on HIV Primary Care Guidelines

Overview Assessment of Needs The IAS-USA is pleased to present this webinar in partnership with the HIV Medicine Association of the Infectious Diseases Society of America (HIVMA/IDSA), which periodically updates its guidance for providers of care for persons with HIV to better enable clinicians to optimize care engagement, medication adherence, and viral suppression. (more…)

DETAIL
Dec
11

Gender-Affirming Hormone Care for People With HIV

Overview Assessment of Needs Transgender and gender-diverse individuals with HIV encounter unique barriers to health care. This webinar will describe current and evolving strategies to improve HIV care, including the effects of gender-affirming care on antiretroviral therapy and HIV outcomes. Best practices in hormone therapy management and strategies to incorporate transgender-competent health care (more…)

DETAIL
Dec
16

Treatment and Prevention of Tuberculosis in People With HIV: Where Are We in 2024?

Overview Assessment of Needs Globally, tuberculosis (TB) is the most common opportunistic infection in people living with HIV. Many coinfected patients first present with advanced immunosuppression and require antiretroviral therapy (ART) initiation during TB treatment. The incidence of TB in patients established on ART remains high. Cotreatment presents several management challenges. Recent data on (more…)

DETAIL